LMAT vs. STVN, GKOS, IRTC, NARI, TMDX, BLCO, SLNO, INSP, NVST, and PRCT
Should you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.
LeMaitre Vascular vs. Its Competitors
Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.
LeMaitre Vascular has a net margin of 19.96% compared to Stevanato Group's net margin of 11.14%. LeMaitre Vascular's return on equity of 13.53% beat Stevanato Group's return on equity.
LeMaitre Vascular has a consensus price target of $97.83, suggesting a potential upside of 16.68%. Given LeMaitre Vascular's higher possible upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.
84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 9.5% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Stevanato Group had 7 more articles in the media than LeMaitre Vascular. MarketBeat recorded 9 mentions for Stevanato Group and 2 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.20 beat Stevanato Group's score of 0.43 indicating that LeMaitre Vascular is being referred to more favorably in the news media.
Stevanato Group has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
Summary
LeMaitre Vascular beats Stevanato Group on 10 of the 17 factors compared between the two stocks.
Get LeMaitre Vascular News Delivered to You Automatically
Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LeMaitre Vascular Competitors List
Related Companies and Tools
This page (NASDAQ:LMAT) was last updated on 7/3/2025 by MarketBeat.com Staff
